Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma

Study Title

Efficacy of Inhaled Albuterol Spiromaxֲ® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

Teva Identifier

ABS-AS-304

ClinicalTrials.gov Identifier

NCT01747629

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Placebo MDPI | Drug: Albuterol MDPI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

12/01/2012 - 11/01/2013

Phase

Phase 3

Study Type

Interventional